Allspring Global Investments Holdings, LLC Vaxcyte, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 343,552 shares of PCVX stock, worth $38.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
343,552
Previous 47,388
624.98%
Holding current value
$38.2 Million
Previous $3.24 Million
701.39%
% of portfolio
0.04%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding PCVX
# of Institutions
287Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.09 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$986 Million0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$913 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$511 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.6B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...